Table 2.
Patient baseline demographic characteristics
| Parameter | Treatment group* | All N = 239 | |
|---|---|---|---|
| 0.59-mg n = 117 | 2.1-mg n = 122 | ||
| Age (years) | |||
| Mean (standard deviation) | 42.5 (14.1) | 40.4 (12.5) | 41.4 (13.3) |
| Range (min–max) | 12.0–74.0 | 15.0–92.0 | 12.0–92.0 |
| Race, n (%) | |||
| Caucasian | 24 (20.5) | 28 (23.0) | 52 (21.8) |
| African American | 3 (2.6) | 4 (3.3) | 7 (2.9) |
| Asian | 83 (70.9) | 84 (68.9) | 167 (69.9) |
| Hispanic | 2 (1.7) | 2 (1.6) | 4 (1.7) |
| Other | 5 (4.3) | 4 (3.3) | 9 (3.8) |
| Gender, n (%) | |||
| Male | 47 (40.2) | 58 (47.5) | 105 (43.9) |
| Female | 70 (59.8) | 64 (52.5) | 134 (56.1) |
| Laterality of uveitis, n (%) | |||
| Unilateral | 23 (19.7) | 24 (19.7) | 47 (19.7) |
| Bilateral | 94 (80.3) | 98 (80.3) | 192 (80.3) |
| Previous uveitis treatment, n (%) | |||
| Systemic | 89 (76.1) | 87 (71.3) | 176 (73.6) |
| Local | 28 (23.9) | 35 (28.7) | 63 (26.4) |
* P > 0.05 for all comparisons of baseline characteristics between treatment groups (analysis of variance for continuous variables; χ 2 test for categorical variables)